These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37365871)

  • 1. Glutamate infusion associated with reduced rises of p-Copeptin after coronary surgery: Substudy of GLUTAMICS II.
    Svedjeholm R; Ferrari G; Vanky F; Friberg Ö; Holm J
    Acta Anaesthesiol Scand; 2023 Nov; 67(10):1373-1382. PubMed ID: 37365871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glutamate infusion on NT-proBNP after coronary artery bypass grafting in high-risk patients (GLUTAMICS II): A randomized controlled trial.
    Holm J; Ferrari G; Holmgren A; Vanky F; Friberg Ö; Vidlund M; Svedjeholm R
    PLoS Med; 2022 May; 19(5):e1003997. PubMed ID: 35533197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study.
    Jiang H; Holm J; Vidlund M; Vanky F; Friberg Ö; Yang Y; Svedjeholm R
    J Transl Med; 2020 May; 18(1):193. PubMed ID: 32393387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate Infusion Reduces Myocardial Dysfunction after Coronary Artery Bypass Grafting According to NT-proBNP: Summary of 2 Randomized Controlled Trials (GLUTAmate for Metabolic Intervention in Coronary Surgery [GLUTAMICS I-II]).
    Holm J; Vanky F; Svedjeholm R
    Am J Clin Nutr; 2023 Nov; 118(5):930-937. PubMed ID: 37657522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery: A Pooled Analysis of 2 Randomized Clinical Trials.
    Holm J; Vanky F; Svedjeholm R
    JAMA Netw Open; 2024 Jan; 7(1):e2351743. PubMed ID: 38252440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUTAMICS--a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome.
    Vidlund M; Håkanson E; Friberg O; Juhl-Andersen S; Holm J; Vanky F; Sunnermalm L; Borg JO; Sharma R; Svedjeholm R
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):922-930.e7. PubMed ID: 22721612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg.
    Vidlund M; Tajik B; Håkanson E; Friberg Ö; Holm J; Vanky F; Svedjeholm R
    BMC Anesthesiol; 2016 Aug; 16(1):54. PubMed ID: 27484576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency.
    Donegan D; Bornhorst J; Van Gompel J; Atkinson J; Theobald JP; Meyer FF; Link MJ; Peris-Celda M; Spears G; Erickson D
    J Neurosurg; 2024 May; 140(5):1276-1284. PubMed ID: 37948691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Temizturk Z; Azboy D; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E038-E047. PubMed ID: 33635267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S-100B substudy of the GLUTAMICS trial: glutamate infusion not associated with sustained elevation of plasma S-100B after coronary surgery.
    Vidlund M; Holm J; Håkanson E; Friberg O; Sunnermalm L; Vanky F; Svedjeholm R
    Clin Nutr; 2010 Jun; 29(3):358-64. PubMed ID: 19853332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid-enriched glucose-insulin-potassium infusion improves hemodynamic function after coronary bypass surgery. A double-blind study in patients with unstable angina and/or compromised left ventricular function.
    Wistbacka JO; Lepojärvi MV; Karlqvist KE; Koistinen J; Kaukoranta PK; Nissinen J; Peltola T; Rainio P; Ruokonen A; Nuutinen LS
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):82-90. PubMed ID: 7787408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glutamate infusion on cardiac performance is independent of changes in metabolism in patients undergoing routine coronary artery bypass surgery.
    Langenberg CJ; Pietersen HG; Geskes G; Wagenmakers AJ; Lange SD; Schouten HJ; Soeters PB
    Clin Sci (Lond); 2001 Dec; 101(6):573-80. PubMed ID: 11724641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration.
    Colson PH; Bernard C; Struck J; Morgenthaler NG; Albat B; Guillon G
    Crit Care; 2011; 15(5):R255. PubMed ID: 22026977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative plasma copeptin levels independently predict delirium and cognitive dysfunction after coronary artery bypass graft surgery.
    Dong S; Li CL; Liang WD; Chen MH; Bi YT; Li XW
    Peptides; 2014 Sep; 59():70-4. PubMed ID: 25073070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The supportive value of pre-bypass L-glutamate loading in patients undergoing coronary artery bypass grafting.
    Bitzikas G; Papakonstantinou C; Lazou A; Bougioukas G; Toumpouras M; Tripsianis G; Spanos P
    J Cardiovasc Surg (Torino); 2005 Dec; 46(6):551-7. PubMed ID: 16424843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin Release in Cardiac Surgery-A New Biomarker to Identify Risk Patients?
    Holm J; Szabó Z; Alehagen U; Lindahl TL; Cederholm I
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):245-250. PubMed ID: 29102258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.
    Muehlschlegel JD; Perry TE; Liu KY; Fox AA; Collard CD; Shernan SK; Body SC
    Anesth Analg; 2010 Nov; 111(5):1101-9. PubMed ID: 20457766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.